Cargando…
SARS-CoV-2 vaccine research and development: Conventional vaccines and biomimetic nanotechnology strategies
The development of a massively producible vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is essential for stopping the current coronavirus disease (COVID-19) pandemic. A vaccine must stimulate effective antibody and T cell responses in vivo to indu...
Autores principales: | Huang, Lanxiang, Rong, Yuan, Pan, Qin, Yi, Kezhen, Tang, Xuan, Zhang, Qian, Wang, Wei, Wu, Jianyuan, Wang, Fubing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shenyang Pharmaceutical University
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462629/ https://www.ncbi.nlm.nih.gov/pubmed/32905011 http://dx.doi.org/10.1016/j.ajps.2020.08.001 |
Ejemplares similares
-
Circular RNAs Are Promising Biomarkers in Liquid Biopsy for the Diagnosis of Non-small Cell Lung Cancer
por: Huang, Lanxiang, et al.
Publicado: (2021) -
COVID-19: advance in laboratory diagnostic strategy and technology
por: Yi, Kezhen, et al.
Publicado: (2021) -
Biomimetic Nanotechnology for SARS-CoV-2 Treatment
por: Li, Shuo, et al.
Publicado: (2023) -
Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer
por: Huang, Lanxiang, et al.
Publicado: (2022) -
Circulating tumor cells in hepatocellular carcinoma: single-cell based analysis, preclinical models, and clinical applications
por: Zhang, Qian, et al.
Publicado: (2020)